IL-33 binds to IL-1 receptor appendages on a variety of cells through long-form serum stimulating factor-2 (ST2) and activates mouse and human ILC2s, leading to the development and aggravation of asthma and AD (188, 189). Here, IL33 is linked to Alzheimer disease.